University of Vermont

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1791-01-01

Employees: 51

Market Cap: -

Website: http://www.uvm.edu

Clinical Trials

Improving Effective Contraceptive Use Among Opioid-maintained Women

Phase 1

Completed

Conditions: Opioid Dependence
Contraceptive Usage

Interventions: Behavioral: Contraceptive management program
Other: Usual care

First Posted Date: 2011-08-29

Last Posted Date: 2015-03-17

Lead Sponsor: University of Vermont

Target Recruit Count: 31

Registration Number: NCT01425060

Locations: 🇺🇸
University of Vermont Substance Abuse Treatment Center, Burlington, Vermont, United States

Peginterferon and Ribavirin, With or Without Telaprevir, for Genotype 1 Hepatitis C and IL28B CC Polymorphism

Phase 4

Withdrawn

Conditions: Hepatitis C

Interventions: Drug: Peginterferon alfa-2a
Drug: Ribavirin
Drug: telaprevir

First Posted Date: 2011-08-11

Last Posted Date: 2017-05-09

Lead Sponsor: University of Vermont

Registration Number: NCT01415141

Locations: 🇺🇸
Emory University School of Medicine, Atlanta, Georgia, United States
🇺🇸
Fletcher Allen Health Care, Burlington, Vermont, United States

Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in Bangladesh

Phase 3

Completed

Conditions: Rotavirus Diarrhea
Vaccine Virus Shedding
Tropical Enteropathy

Interventions: Biological: Rotarix
Biological: IPV

First Posted Date: 2011-06-17

Last Posted Date: 2015-04-14

Lead Sponsor: University of Vermont

Target Recruit Count: 700

Registration Number: NCT01375647

Locations: 🇧🇩
International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh

Nasogastric Tube Insertion Using Midazolam in the Emergency Department

Phase 4

Completed

Conditions: Intubation; Difficult

Interventions: Drug: Midazolam

First Posted Date: 2011-06-17

Last Posted Date: 2013-07-22

Lead Sponsor: University of Vermont

Target Recruit Count: 49

Registration Number: NCT01375634

Locations: 🇺🇸
Fletcher Allen Health Care Emergency Department, Burlington, Vermont, United States

Mechanisms of Specific Trunk Exercises in Low Back Pain

Not Applicable

Completed

Conditions: Low Back Pain

Interventions: Other: Physical Therapy rehabilitation. Movement System Impairment (MSI) classification based exercise

First Posted Date: 2011-05-27

Last Posted Date: 2017-06-05

Lead Sponsor: University of Vermont

Target Recruit Count: 102

Registration Number: NCT01362049

Locations: 🇺🇸
Human Motion Analysis Lab, Burlington, Vermont, United States

The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins

Completed

Conditions: Breast Cancer

First Posted Date: 2011-04-25

Last Posted Date: 2020-09-17

Lead Sponsor: University of Vermont

Target Recruit Count: 30

Registration Number: NCT01341171

Locations: 🇺🇸
University of Vermont, Burlington, Vermont, United States

Evaluation of Loratadine for Prevention of Pegfilgrastim-Induced Pain

Phase 2

Conditions: Pegfilgrastim-induced Back and Leg Pain

Interventions: Drug: Loratadine
Drug: placebo

First Posted Date: 2011-03-09

Last Posted Date: 2013-01-24

Lead Sponsor: University of Vermont

Target Recruit Count: 55

Registration Number: NCT01311336

Locations: 🇺🇸
York Hospital, York, Maine, United States
🇺🇸
Mountainview Medical Center, Berlin, Vermont, United States
🇺🇸
Cancer Care of Maine, Brewer, Maine, United States

and more 4 locations

Evaluation of the Role of Prostaglandins in Radiation-induced Mucositis

Completed

Conditions: Cancer of the Head and Neck
Radiotherapy

First Posted Date: 2010-12-03

Last Posted Date: 2014-02-04

Lead Sponsor: University of Vermont

Target Recruit Count: 9

Registration Number: NCT01252498

Locations: 🇺🇸
Fletcher Allen Health Care, Burlington, Vermont, United States

Internet Obesity Treatment Enhanced With Motivational Interviewing

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: Internet Obesity Treatment
Behavioral: Internet Obesity Treatment with MI
Behavioral: Contingent MI

First Posted Date: 2010-11-02

Last Posted Date: 2018-12-24

Lead Sponsor: University of Vermont

Target Recruit Count: 495

Registration Number: NCT01232699

Locations: 🇺🇸
Behavioral Weight Management Program/Univ of Vermont, Burlington, Vermont, United States
🇺🇸
University of Arkansas for the Medical Sciences, Little Rock, Arkansas, United States

Nicotine Treatment of Impulsivity in Parkinson's Disease

Phase 4

Conditions: Parkinson's Disease

Interventions: Drug: nicotine patch
Drug: placebo

First Posted Date: 2010-10-07

Last Posted Date: 2013-05-14

Lead Sponsor: University of Vermont

Target Recruit Count: 20

Registration Number: NCT01216904

Locations: 🇺🇸
Fletcher Allen Health Care/UVM, Burlington, Vermont, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy